Cepheid
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1996-01-01
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.cepheid.com
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
Completed
- Conditions
- HCV
- Interventions
- Diagnostic Test: Xpert HCV
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 1012
- Registration Number
- NCT06508996
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)
Completed
- Conditions
- Non-muscle-invasive Bladder Cancer
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2023-02-13
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 852
- Registration Number
- NCT03664258
- Locations
- 🇳🇱
Academic Medical Center, Amsterdam, Netherlands
🇪🇸Fundacio Puigvert, Barcelona, Spain
🇦🇹University Clinic for Urology and Andrology, Salzburg, Austria
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
Completed
- Conditions
- Leukemia, Myelogenous, Chronic
- Interventions
- Device: Xpert BCR-ABL Ultra
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 266
- Registration Number
- NCT03421626
- Locations
- 🇺🇸
St. Alphonsus Regional Medical Center, Boise, Idaho, United States
🇺🇸WJB Dorn VA Medical Center, Columbia, South Carolina, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
Completed
- Conditions
- Bladder Cancer
- Interventions
- Device: Xpert Bladder Cancer Monitor
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 424
- Registration Number
- NCT03125460
- Locations
- 🇺🇸
Idaho Urologic Institute, Meridian, Idaho, United States
🇺🇸UroPartners, Melrose Park, Illinois, United States
🇺🇸Urology Associates, P.C., Englewood, Colorado, United States
Clinical Evaluation of the Xpert® HIV-1 VL
Completed
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Device: Xpert HIV-1 VL Assay
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 966
- Registration Number
- NCT02461576
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Cepheid
- Target Recruit Count
- 992
- Registration Number
- NCT01587469
- Locations
- 🇺🇸
Ucsf Aids Ctu, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath